FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108592009> ?p ?o ?g. }

• W2108592009 endingPage "174" @default.
• W2108592009 startingPage "166" @default.
• W2108592009 abstract "Abstract —Carvedilol, a new vasodilating β-adrenoceptor antagonist and a potent antioxidant, produces a high degree of cardioprotection in a variety of experimental models of ischemic cardiac injury. Recent clinical studies in patients with heart failure have demonstrated that carvedilol reduces morbidity and mortality and inhibits cardiac remodeling. The present study was designed to explore whether the protective effects of carvedilol on the ischemic myocardium include inhibition of apoptosis of cardiomyocytes and, if so, to determine its mechanism of action. Anesthetized rabbits were subjected to 30 minutes of coronary artery occlusion followed by 4 hours of reperfusion. Detection of apoptosis of cardiomyocytes was based on the presence of nucleosomal DNA fragments on agarose gels (DNA ladder) and in situ nick end labeling. Carvedilol (1 mg/kg IV), administered 5 minutes before reperfusion, reduced the number of apoptotic myocytes in the ischemic area from 14.7±0.4% to 3.4±1.8% (77% reduction, P <.001). Propranolol, administered at equipotent β-blocking dosage, reduced the number of apoptotic myocytes to 8.9±2.1% (39% reduction, P <.05). DNA ladders were observed in the hearts of all six vehicle-treated rabbits but only one of six carvedilol-treated rabbits ( P <.01). Immunocytochemical analysis of rabbit hearts demonstrated an upregulation of Fas protein in ischemic cardiomyocytes, and treatment with carvedilol reduced both the intensity of staining as well as the area stained. Myocardial ischemia/reperfusion led to a rapid activation of stress-activated protein kinase (SAPK) in the ischemic area but not in nonischemic regions. SAPK activity was increased from 2.1±0.3 mU/mg (basal) to 8.9±0.8 mU/mg after 30 minutes of ischemia followed by 20 minutes of reperfusion. Carvedilol inhibited the activation of SAPK by 53.4±6.5% ( P <.05). Under the same conditions, propranolol (1 mg/kg) had no effect on SAPK activation. Taken together, these results suggest that carvedilol prevents myocardial ischemia/reperfusion–induced apoptosis in cardiomyocytes possibly by downregulation of the SAPK signaling pathway, by inhibition of Fas receptor expression, and by β-adrenergic blockade. The former two actions represent novel and important mechanisms that may contribute to the cardioprotective effects of carvedilol." @default.
• W2108592009 created "2016-06-24" @default.
• W2108592009 creator A5001706891 @default.
• W2108592009 creator A5003026401 @default.
• W2108592009 creator A5012502619 @default.
• W2108592009 creator A5017973561 @default.
• W2108592009 creator A5020434153 @default.
• W2108592009 creator A5025105178 @default.
• W2108592009 creator A5029218445 @default.
• W2108592009 creator A5039672117 @default.
• W2108592009 creator A5071610740 @default.
• W2108592009 creator A5073852873 @default.
• W2108592009 creator A5078873886 @default.
• W2108592009 date "1998-02-09" @default.
• W2108592009 modified "2023-10-09" @default.
• W2108592009 title "Possible Involvement of Stress-Activated Protein Kinase Signaling Pathway and Fas Receptor Expression in Prevention of Ischemia/Reperfusion-Induced Cardiomyocyte Apoptosis by Carvedilol" @default.
• W2108592009 cites W1646722613 @default.
• W2108592009 cites W1967128858 @default.
• W2108592009 cites W1969158591 @default.
• W2108592009 cites W1976385326 @default.
• W2108592009 cites W1981883990 @default.
• W2108592009 cites W1990543022 @default.
• W2108592009 cites W2002564316 @default.
• W2108592009 cites W2003962192 @default.
• W2108592009 cites W2008318207 @default.
• W2108592009 cites W2013936743 @default.
• W2108592009 cites W2026669227 @default.
• W2108592009 cites W2026951979 @default.
• W2108592009 cites W2041466047 @default.
• W2108592009 cites W2053640261 @default.
• W2108592009 cites W2075518730 @default.
• W2108592009 cites W2076188957 @default.
• W2108592009 cites W2077880395 @default.
• W2108592009 cites W2088749722 @default.
• W2108592009 cites W2097232891 @default.
• W2108592009 cites W2126636055 @default.
• W2108592009 cites W2140852350 @default.
• W2108592009 cites W2152594429 @default.
• W2108592009 cites W2171526567 @default.
• W2108592009 cites W2187963245 @default.
• W2108592009 cites W2229384143 @default.
• W2108592009 cites W2326508838 @default.
• W2108592009 cites W2335254843 @default.
• W2108592009 cites W4294112996 @default.
• W2108592009 doi "https://doi.org/10.1161/01.res.82.2.166" @default.
• W2108592009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9468187" @default.
• W2108592009 hasPublicationYear "1998" @default.
• W2108592009 type Work @default.
• W2108592009 sameAs 2108592009 @default.
• W2108592009 citedByCount "215" @default.
• W2108592009 countsByYear W21085920092012 @default.
• W2108592009 countsByYear W21085920092013 @default.
• W2108592009 countsByYear W21085920092014 @default.
• W2108592009 countsByYear W21085920092015 @default.
• W2108592009 countsByYear W21085920092016 @default.
• W2108592009 countsByYear W21085920092018 @default.
• W2108592009 countsByYear W21085920092019 @default.
• W2108592009 countsByYear W21085920092022 @default.
• W2108592009 crossrefType "journal-article" @default.
• W2108592009 hasAuthorship W2108592009A5001706891 @default.
• W2108592009 hasAuthorship W2108592009A5003026401 @default.
• W2108592009 hasAuthorship W2108592009A5012502619 @default.
• W2108592009 hasAuthorship W2108592009A5017973561 @default.
• W2108592009 hasAuthorship W2108592009A5020434153 @default.
• W2108592009 hasAuthorship W2108592009A5025105178 @default.
• W2108592009 hasAuthorship W2108592009A5029218445 @default.
• W2108592009 hasAuthorship W2108592009A5039672117 @default.
• W2108592009 hasAuthorship W2108592009A5071610740 @default.
• W2108592009 hasAuthorship W2108592009A5073852873 @default.
• W2108592009 hasAuthorship W2108592009A5078873886 @default.
• W2108592009 hasBestOaLocation W21085920091 @default.
• W2108592009 hasConcept C126322002 @default.
• W2108592009 hasConcept C164705383 @default.
• W2108592009 hasConcept C185592680 @default.
• W2108592009 hasConcept C190283241 @default.
• W2108592009 hasConcept C207200792 @default.
• W2108592009 hasConcept C2778151854 @default.
• W2108592009 hasConcept C2778198053 @default.
• W2108592009 hasConcept C2779311647 @default.
• W2108592009 hasConcept C2779676291 @default.
• W2108592009 hasConcept C2780114680 @default.
• W2108592009 hasConcept C2780591200 @default.
• W2108592009 hasConcept C541997718 @default.
• W2108592009 hasConcept C55493867 @default.
• W2108592009 hasConcept C71924100 @default.
• W2108592009 hasConcept C98274493 @default.
• W2108592009 hasConceptScore W2108592009C126322002 @default.
• W2108592009 hasConceptScore W2108592009C164705383 @default.
• W2108592009 hasConceptScore W2108592009C185592680 @default.
• W2108592009 hasConceptScore W2108592009C190283241 @default.
• W2108592009 hasConceptScore W2108592009C207200792 @default.
• W2108592009 hasConceptScore W2108592009C2778151854 @default.
• W2108592009 hasConceptScore W2108592009C2778198053 @default.
• W2108592009 hasConceptScore W2108592009C2779311647 @default.
• W2108592009 hasConceptScore W2108592009C2779676291 @default.
• W2108592009 hasConceptScore W2108592009C2780114680 @default.
• W2108592009 hasConceptScore W2108592009C2780591200 @default.
• W2108592009 hasConceptScore W2108592009C541997718 @default.

• next